| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aldeyra Therapeutics, Inc. (ALDX) has 2 insiders with recent SEC Form 4 filings, including 8 buys and 0 sells. ALDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 221.8K | $434.7K | - | |
| Other | 7.5K | $14.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2017 | Douglas Richard | Director | Buy | 40,000 | $4.50 | $180,000.00 | New | |
| Feb 14, 2017 | Perceptive Advisors LLC51 | 10% Owner | Buy | 893,025 | $4.50 | $4,018,612.50 | +52.6% | |
| May 26, 2016 | Perceptive Advisors LLC51 | 10% Owner | Buy | 700,000 | $5.00 | $3,500,000.00 | +56.4% | |
| Oct 28, 2015 | Perceptive Advisors LLC51 | 10% Owner | Buy | 45,100 | $6.50 | $293,150.00 | +3.8% | |
| Oct 26, 2015 | Perceptive Advisors LLC51 | 10% Owner | Buy | 50,000 | $6.46 | $323,150.00 | +4.4% | |
| Oct 22, 2015 | Perceptive Advisors LLC51 | 10% Owner | Buy | 18,020 | $6.47 | $116,661.48 | +1.6% | |
| Oct 20, 2015 | Perceptive Advisors LLC51 | 10% Owner | Buy | 37,145 | $6.39 | $237,193.28 | +1.7% |